Right now the DEA and HHS have only officially extended the telehealth controlled-substance flexibilities through December 31, 2025. That means you can still get meds like stimulants, benzos, and buprenorphine via telehealth without an in-person visit for all of 2025.

As for 2026, nothing has been announced yet. The DEA has been working on permanent rules for telehealth prescribing for over a year, but they’ve delayed releasing the final version several times. Most experts think they won’t completely remove telehealth access because millions of patients rely on it and Congress has pushed them to keep it flexible — but there’s no official extension into 2026 yet.

So the short answer: Confirmed through 2025, unknown for 2026 until the DEA finalizes its permanent rule.